Test Price
2,800 AED✅ Home Collection Available
CACNA1A Gene Spinocerebellar Ataxia Type 6 (SCA6) Genetic Test in UAE | 2,800 AED | 2026 DHA Guidelines
تحليل جين CACNA1A للرنح النخاعي المخيخي من النوع السادس (SCA6) في الإمارات | ٢٨٠٠ درهم | معتمد من هيئة الصحة بدبي ٢٠٢٦
Executive Summary
This comprehensive Next‑Generation Sequencing (NGS) analysis targets the entire CACNA1A gene to definitively diagnose autosomal dominant Spinocerebellar Ataxia Type 6 (SCA6). Delivered under DHA‑regulated protocols with ISO 9001:2015 certified laboratory processing, the test guarantees 99.9% diagnostic sensitivity.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Hospital‑Grade Home Collection with ISO Certified Cold‑Chain Transport (8 AM – 11 PM) and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post‑Test Consultation for result interpretation by a DHA‑licensed neurologist.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
يقدم هذا التحليل الجيني دقة تشخيصية فائقة (99.9%) وفق معايير مختبر معتمد آيزو 9001:2015، مع خدمة سحب دم منزلي متميزة وحفظ العينات بسلسلة تبريد، واستشارات طبية هاتفية بعد النتيجة.
Overview
The CACNA1A gene encodes a calcium channel subunit critical for Purkinje neuron function. Mutations cause Spinocerebellar Ataxia Type 6, a late‑onset autosomal dominant neurodegenerative disorder characterized by progressive cerebellar ataxia, dysarthria, and nystagmus. هذا التحليل الجيني يوفر تأكيداً جزيئياً للمرض الوراثي السائد عند وجود تاريخ عائلي أو أعراض سريرية مشتبهة.
| Parameter | Our Test (NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | 99.9% sensitivity for pathogenic variants in CACNA1A | Detects known mutations only; may miss novel variants |
| Methodology | Full‑gene Next‑Generation Sequencing with copy‑number analysis | Targeted Sanger sequencing of selected exons |
| Turnaround Time | 3 to 4 Weeks | 4 to 6 Weeks (often with reflex to broader panels) |
Pre‑Test Requirements
A pre‑test genetic counselling session to draw a pedigree chart of family members affected with SCA6 is strongly recommended. Provide a detailed clinical history of the patient. No special fasting is required; sample types accepted: Whole Blood (standard venipuncture), Extracted DNA, or One Drop Blood on FTA Card. All specimens must be transported under cold‑chain conditions. Do not discontinue any prescribed medication without consulting your physician.
Physician Insight & Safety Protocol
“As a clinical neurologist, I understand that a genetic diagnosis of SCA6 can feel overwhelming, but this NGS test provides the definitive molecular answer you need to plan for the future. Always correlate the genetic result with a thorough neurological examination and family history before making any clinical decisions. My commitment is to guide you through the interpretation with empathy and evidence‑based care.”
— Dr. Prabhakar Reddy, Consultant Neurologist (DHA License: 61713011)
⚠️ Medication Warning: Do not discontinue prescribed medication without consulting your doctor. This genetic test does not replace ongoing neurological management.
Safety Exclusion Criteria & Emergency Red Flags
- Patients unable to provide informed consent or minors without parental/guardian approval (in strict compliance with UAE CDS Law 2026).
- Acute hospitalisation or unstable medical condition that would compromise safe sample collection.
- Prior receipt of an allogeneic bone marrow transplant, which may interfere with germline DNA analysis.
- ER Red Flags: If you experience sudden loss of consciousness, severe breathing difficulty, or a rapidly worsening ataxic gait, proceed to the nearest emergency department immediately. A positive test result is not a medical emergency but new neurological deficits require urgent evaluation.
Patient FAQ & Clinical Guidance
What is the clinical purpose of the CACNA1A SCA6 NGS test?
This NGS test provides definitive genetic confirmation of autosomal dominant spinocerebellar ataxia type 6 (SCA6). It identifies missense, nonsense, splice‑site, and exon‑level copy number variants in the CACNA1A gene. Conclusive results enable accurate genetic counselling, prognosis, and eligibility for emerging disease‑modifying therapies under research protocols in the UAE.
يقدم هذا الاختبار تأكيداً جينياً قاطعاً للرنح النخاعي المخيخي من النوع السادس الوراثي السائد. يتم عبر تحليل تسلسلي كامل لجين CACNA1A، مما يساعد في التشخيص الدقيق والاستشارة الوراثية ومتابعة العلاج.
How should I prepare for this test?
Pre‑test genetic counselling and a detailed family pedigree chart are strongly mandatory before sample collection. Document any existing neurological symptoms and bring previous MRI reports. There is no fasting requirement; however, inform the phlebotomist of any anticoagulant therapy. The sample must be taken by a trained professional using aseptic technique and immediately placed in the designated cold‑chain kit.
الاستشارة الوراثية قبل الاختبار ورسم شجرة عائلية مفصلة إلزامية قبل سحب العينة. أحضر التقارير الطبية السابقة ولا حاجة للصيام مع إبلاغ المسؤول عن أي علاج مميع للدم.
What do I do if I test positive for SCA6?
If you test positive, immediately consult your neurologist to discuss management options and family implications. A positive result confirms the diagnosis but does not predict exact disease progression. Your specialist will recommend symptomatic treatment, physiotherapy, and regular neurological follow‑up. Genetic counselling for at‑risk relatives is essential to enable informed family planning decisions.
في حالة النتيجة الإيجابية، استشر طبيب الأعصاب فوراً لمناقشة خطة العلاج الضرورية والتأثيرات العائلية المحتملة. سيتم التوصية بالعلاج الطبيعي والمتابعة الدورية للجهاز العصبي، مع تقديم المشورة الوراثية للأقارب.
UAE Regulatory & Data Privacy Compliance
This genetic is conducted in full alignment with Federal Decree‑Law No. 41 of 2024 on Human Genomic Data (Article 87), UAE PDPL (Federal Decree‑Law No. 45 of 2021), and CDS Law 2026 governing minors’ consent. The laboratory operates under DHA facility license 9834453 and ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139). All patient data are encrypted, stored within UAE sovereign servers, and never shared without explicit informed consent.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians